Showing results (781-790 of 1,129) with videos related to
Sort By:
Pageof 113
Best Practice & Research. Clinical Haematology|December 3, 2014
Will novel agents for ALL finally change the natural history?Dan DouerBest Practice & Research. Clinical Haematology|December 3, 2014
MRD in AML: it is time to change the definition of remissionGert J Ossenkoppele, Gerrit Jan SchuurhuisBest Practice & Research. Clinical Haematology|December 3, 2014
Unrelated donor transplantation: peripheral blood or bone marrow--does it matter?Mary EapenBest Practice & Research. Clinical Haematology|December 3, 2014
The new thrombopoietic agenda: impact on leukemias and MDSJames B BusselBest Practice & Research. Clinical Haematology|March 7, 2020
Maintenance therapy and need for cessation studies in multiple myeloma: Focus on the futureBenjamin Diamond, Kylee Maclachlan, David J Chung, et al.Best Practice & Research. Clinical Haematology|March 7, 2020
Second malignancies in multiple myeloma; emerging patterns and future directionsKylee Maclachlan, Benjamin Diamond, Francesco Maura, et al.Best Practice & Research. Clinical Haematology|March 7, 2020
Current and potential applications of positron emission tomography for multiple myeloma and plasma cell disordersGary A Ulaner, C Ola LandgrenBest Practice & Research. Clinical Haematology|March 7, 2020
Monitoring minimal residual disease in the bone marrow using next generation sequencingEven H Rustad, Eileen M BoyleBest Practice & Research. Clinical Haematology|August 27, 2022
Blood coagulation and cancer genesNadim Tawil, Janusz RakBest Practice & Research. Clinical Haematology|December 6, 2021
Current status of pretransplant intensive chemotherapy or hypomethylating agents for myelodysplastic syndromeChristian Niederwieser, Nicolaus KrögerPageof 113